Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Principal Financial Group Inc Common Stock (PFG) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Principal Financial Group Inc Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Principal Financial Group Inc Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Principal Financial Group Inc Common Stock trades at $106.98 (market cap $23.04B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Principal Financial Group Inc Common Stock is far larger — about 12.8× Vir Biotechnology Inc. Common Stock's market cap, and Principal Financial Group Inc Common Stock pays a 3.12% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Principal Financial Group Inc Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

PFGVIR
Market Cap
$23.04B$1.80B
Volume
1,066,5681,782,836
Sector
FinancialsHealth
52-Week High
$118.51$11.78
52-Week Low
$78.39$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$22.12B$1.36B
Dividend Yield
3.12%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Principal Financial Group Inc Common Stock

Principal Financial Group (PFG) trades at $107.64, down 0.19% with a bearish technical outlook. The stock shows mixed fundamentals with recent earnings beats but faces valuation concerns at a P/E of 15.33. Recent acquisition of Beam Benefits aims to expand digital capabilities in specialty benefits, while analyst sentiment remains cautious with a 'Hold' consensus rating and $108.33 price target.

PFG presents a balanced risk-reward profile with steady revenue growth and improving profit margins, but faces headwinds from technical weakness and mixed analyst sentiment. The Beam Benefits acquisition provides growth potential in the SMB market, though execution risks and competitive pressures in the multiline insurance sector warrant monitoring for investors seeking exposure to financial services.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PFG

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Principal Financial Group Inc Common Stock

Principal Financial Group provides retirement, insurance, and asset management services. It serves individuals, employers, and institutional clients.

Read more on PFG →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →